Modulation of tau phosphorylation by environmental copper. - Wikidata - wikimedia - TriplyDB

Modulation of tau phosphorylation by environmental copper.

Modulation of tau phosphorylation by environmental copper.

http://www.wikidata.org/entity/Q30620072

about

A time-course analysis of changes in cerebral metal levels following a controlled cortical impact.Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.Metal Ion Effects on Aβ and Tau Aggregation.Neurotoxicity of Copper.Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.Copper in Alzheimer’s disease: Implications in amyloid aggregation and neurotoxicity

P2860

Q35874134-F4B219BA-170B-40B6-A110-E22180A4F088 Q36557426-BAF8DB45-60CA-4392-9928-F611287C2F88 Q47883269-DF5CA438-36CB-476B-B988-A1BF59C3107F Q48120135-73BC6871-5401-4CB7-A57A-E2C99C540CC1 Q50053720-D02A2841-A6F4-4ACB-B5E0-033A0CECE83D Q58863948-A2067691-F3A6-4497-B928-E20D7A576E0F

P2860

Modulation of tau phosphorylation by environmental copper.

http://www.wikidata.org/entity/Q30620072

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Modulation of tau phosphorylation by environmental copper.

@ast

Modulation of tau phosphorylation by environmental copper.

@en

type

label

Modulation of tau phosphorylation by environmental copper.

@ast

Modulation of tau phosphorylation by environmental copper.

@en

prefLabel

Modulation of tau phosphorylation by environmental copper.

@ast

Modulation of tau phosphorylation by environmental copper.

@en

P1433

Q30620072-2194D8B6-321C-404F-AE91-1ED9F244A74F

P1476

Q30620072-6033D9B3-DE9E-4091-9F2E-FCAF80E38CC7

P2093

Q30620072-5808B5BA-C42B-4DBD-8D57-F747ECA2FB15

Q30620072-61254F98-83A2-4ABB-849C-27B10AFB6FA7

Q30620072-68FD7E0A-E1E1-4117-BAAC-3373096D1A91

Q30620072-77A4E4E6-2283-41CE-8EB9-4A5195425307

Q30620072-ED5D1051-92DF-491B-B7A8-E7222FEC4DDF

P2860

Q30620072-06D5A278-DBEC-464E-AD8C-3854CD3E87E1

Q30620072-1E07BC70-052F-4575-8C59-D6ED44FE62BC

Q30620072-1FAF1C64-3F82-47E0-B51C-2399D5C7134C

Q30620072-2A6CAC5F-AFD4-4B90-883E-F628A75CD222

Q30620072-2ADF2046-EE43-40B9-8E0D-E71C27827D16

Q30620072-3710AF7A-1258-4E5A-A472-0D494DB3C58C

Q30620072-4EF46DEA-264C-4FB8-BEE6-495B0535FE8B

Q30620072-4FAA7002-D475-4868-9C34-C84724C34C72

Q30620072-575DF1CF-353A-49DF-84B5-ACE8FE6780BE

Q30620072-6BDD0C8A-1FE1-4007-9A36-38647EC8AAF6

P2888

Q30620072-9BE4BDF7-C4F3-4EC8-81F5-68B479A068E2

P304

Q30620072-2AD11F53-9A42-4DE9-BB86-8A1A0466FD51

P31

Q30620072-739A0953-876E-4AFD-9A8D-0773256F52E4

P356

Q30620072-EA1C594F-AC57-4A62-87F7-AF478A1D0EC3

P433

Q30620072-12DB5BB6-C6B6-4F03-9477-6C09542BA5DC

P478

Q30620072-50BE0236-8665-41C6-800A-B2EEC57F8609

P50

Q30620072-F2816DB0-E684-40FA-818E-D030B9498C94

P577

Q30620072-9D6DB7B9-785B-4E8E-93CB-D8B0915AA71E

P5875

Q30620072-E9FAD7F0-A52C-4F9C-94FA-4E8C9B74A3D2

P6179

Q30620072-35F04452-B2AA-4F37-A421-814E03259CF7

P698

Q30620072-17BBF348-EFC4-4FC0-A343-35B546023E75

P921

Q30620072-46F4FB23-0164-47AA-8E3A-5278C44406D4

P932

Q30620072-52243253-2F24-4C80-9CC3-000666CF0CC8

P356

P1433

Translational Neurodegeneration

P1476

Modulation of tau phosphorylation by environmental copper.

@en

P2093

Charles Murchison

http://www.w3.org/2001/XMLSchema#string

Christopher Harris

http://www.w3.org/2001/XMLSchema#string

Kellen Voss

http://www.w3.org/2001/XMLSchema#string

Martina Ralle

http://www.w3.org/2001/XMLSchema#string

Megan Duffy

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease

Copper binding properties of a tau peptide associated with Alzheimer's disease studied by CD, NMR, and MALDI-TOF MS.

Binding of copper (II) ion to an Alzheimer's tau peptide as revealed by MALDI-TOF MS, CD, and NMR.

Oral zinc reduces amyloid burden in Tg2576 mice

Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD

Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

A copper-lowering strategy attenuates amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.

Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction

Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.

P2888

P304

24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2047-9158-3-24

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272191355

http://www.w3.org/2001/XMLSchema#string

P6179

1006124028

http://www.w3.org/2001/XMLSchema#string

P698

25671100

http://www.w3.org/2001/XMLSchema#string

P921

phosphorylation

P932

4322670

http://www.w3.org/2001/XMLSchema#string